Nancy M. Gray

561 total citations
17 papers, 464 citations indexed

About

Nancy M. Gray is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Nancy M. Gray has authored 17 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Nancy M. Gray's work include Pharmacological Receptor Mechanisms and Effects (9 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Nancy M. Gray is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (9 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Nancy M. Gray collaborates with scholars based in United States. Nancy M. Gray's co-authors include Patricia C. Contreras, Thomas H. Lanthorn, Joseph B. Monahan, Paul L. Wood, Tadimeti S. Rao, P. Contreras, Satish Iyengar, A. Cordi, Michael S. Dappen and Steve J. Mick and has published in prestigious journals such as Journal of the American Chemical Society, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Nancy M. Gray

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy M. Gray United States 13 321 296 81 32 28 17 464
S. Grimwood United States 10 213 0.7× 216 0.7× 83 1.0× 34 1.1× 24 0.9× 13 387
Stephen D. Hurt United States 10 351 1.1× 366 1.2× 65 0.8× 32 1.0× 22 0.8× 19 526
A. Cordi France 10 200 0.6× 207 0.7× 60 0.7× 37 1.2× 26 0.9× 15 365
Linda M. Pullan United States 15 382 1.2× 289 1.0× 68 0.8× 58 1.8× 37 1.3× 29 609
Torsten May Germany 12 342 1.1× 283 1.0× 110 1.4× 43 1.3× 14 0.5× 16 559
Rosemarie Tomlinson United Kingdom 8 280 0.9× 421 1.4× 93 1.1× 46 1.4× 28 1.0× 10 741
Jean Rataud France 11 295 0.9× 400 1.4× 69 0.9× 58 1.8× 55 2.0× 19 618
Ian T. Huscroft United Kingdom 9 213 0.7× 282 1.0× 98 1.2× 40 1.3× 47 1.7× 10 442
Kenneth L. Hauser United States 7 239 0.7× 212 0.7× 149 1.8× 54 1.7× 35 1.3× 9 594
Kazuo Koshiya Japan 14 245 0.8× 343 1.2× 38 0.5× 46 1.4× 33 1.2× 25 509

Countries citing papers authored by Nancy M. Gray

Since Specialization
Citations

This map shows the geographic impact of Nancy M. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy M. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy M. Gray more than expected).

Fields of papers citing papers by Nancy M. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy M. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy M. Gray. The network helps show where Nancy M. Gray may publish in the future.

Co-authorship network of co-authors of Nancy M. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy M. Gray. A scholar is included among the top collaborators of Nancy M. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy M. Gray. Nancy M. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rao, Tadimeti S., Nancy M. Gray, Michael S. Dappen, et al.. (1993). Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: In vivo characterization. Neuropharmacology. 32(2). 139–147. 12 indexed citations
2.
Gray, Nancy M., Matthias C. Lu, & Hemendra N. Bhargava. (1993). Pharmacological evaluation of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes, the conformationally rigid analogues of norfenfluramine in mice. General Pharmacology The Vascular System. 24(6). 1343–1349. 2 indexed citations
3.
Contreras, Patricia C., et al.. (1992). BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sciences. 51(14). 1145–1149. 25 indexed citations
4.
Hood, William F., Nancy M. Gray, Michael S. Dappen, et al.. (1992). Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 654–660. 15 indexed citations
5.
6.
Gray, Nancy M., Michael S. Dappen, Bichu Cheng, et al.. (1991). Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor. Journal of Medicinal Chemistry. 34(4). 1283–1292. 39 indexed citations
7.
Contreras, P., Thomas H. Lanthorn, Nancy M. Gray, et al.. (1991). Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil. Brain Research. 546(1). 79–82. 46 indexed citations
9.
Contreras, Patricia C., et al.. (1990). Ifenprodil and SL 82.0715 potently inhibit binding of [3H](+)-3-PPP to σ binding sites in rat brain. Neuroscience Letters. 116(1-2). 190–193. 54 indexed citations
10.
Costa, Brian R. de, Wayne D. Bowen, Andrew Thurkauf, et al.. (1990). Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity .sigma. receptor ligands. Identification of a new class of highly potent and selective .sigma. receptor probes. Journal of Medicinal Chemistry. 33(11). 3100–3110. 30 indexed citations
11.
Gray, Nancy M., et al.. (1990). H1 antihistamines interact with central sigma receptors. Life Sciences. 47(2). 175–180. 18 indexed citations
12.
Wood, Paul L., Tadimeti S. Rao, Smriti Iyengar, et al.. (1990). A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/Glycine/Ion channel receptor macrocomplex. Neurochemical Research. 15(2). 217–230. 54 indexed citations
13.
Gray, Nancy M., et al.. (1989). Phencyclidine-like effects of tetrahydroisoquinolines and related compounds. Journal of Medicinal Chemistry. 32(6). 1242–1248. 50 indexed citations
14.
Contreras, Patricia C., Joseph B. Monahan, Thomas H. Lanthorn, et al.. (1987). Phencyclidine. Molecular Neurobiology. 1(3). 191–211. 48 indexed citations
15.
Gray, Nancy M., Matthias C. Lu, & Hemendra N. Bhargava. (1984). The effects of stereoisomers of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes on food intake, brain serotonin concentration, and monoamine oxidase activity in the rat. Pharmacological Research Communications. 16(3). 281–294. 1 indexed citations
16.
Gray, Nancy M., Ming‐Chun Lu, & Hemendra N. Bhargava. (1982). The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat.. Journal of Pharmacology and Experimental Therapeutics. 221(1). 58–62. 4 indexed citations
17.
Black, Simon & Nancy M. Gray. (1953). ENZYMATIC PHOSPHORYLATION OF l-ASPARTATE. Journal of the American Chemical Society. 75(9). 2271–2272. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026